NO178252C - Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater - Google Patents

Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater

Info

Publication number
NO178252C
NO178252C NO913019A NO913019A NO178252C NO 178252 C NO178252 C NO 178252C NO 913019 A NO913019 A NO 913019A NO 913019 A NO913019 A NO 913019A NO 178252 C NO178252 C NO 178252C
Authority
NO
Norway
Prior art keywords
preparation
orally administrable
novel solid
ifosfamide
preparations
Prior art date
Application number
NO913019A
Other languages
English (en)
Norwegian (no)
Other versions
NO913019L (no
NO913019D0 (no
NO178252B (no
Inventor
Dieter Sauerbier
Jurgen Engel
Eckhard Milsmann
Klaus Molge
Otto Isaac
Original Assignee
Asta Medica Ag
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag, Asta Pharma Ag filed Critical Asta Medica Ag
Publication of NO913019D0 publication Critical patent/NO913019D0/no
Publication of NO913019L publication Critical patent/NO913019L/no
Publication of NO178252B publication Critical patent/NO178252B/no
Publication of NO178252C publication Critical patent/NO178252C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO913019A 1990-08-03 1991-08-02 Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater NO178252C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (4)

Publication Number Publication Date
NO913019D0 NO913019D0 (no) 1991-08-02
NO913019L NO913019L (no) 1992-02-04
NO178252B NO178252B (no) 1995-11-13
NO178252C true NO178252C (no) 1996-02-21

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913019A NO178252C (no) 1990-08-03 1991-08-02 Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater

Country Status (33)

Country Link
US (1) US5158776A (lv)
EP (1) EP0469440B1 (lv)
JP (2) JP3061898B2 (lv)
KR (1) KR0177170B1 (lv)
CN (1) CN1046851C (lv)
AR (1) AR247484A1 (lv)
AT (1) ATE110261T1 (lv)
AU (2) AU643309B2 (lv)
BG (1) BG60900B1 (lv)
CA (1) CA2048367C (lv)
CZ (1) CZ280475B6 (lv)
DE (2) DE4124481A1 (lv)
DK (1) DK0469440T3 (lv)
EG (1) EG19690A (lv)
ES (1) ES2058999T3 (lv)
FI (1) FI97951C (lv)
HK (1) HK15695A (lv)
HR (1) HRP920575B1 (lv)
HU (1) HU206268B (lv)
IE (1) IE66378B1 (lv)
IL (1) IL99031A (lv)
LT (1) LT3528B (lv)
LV (1) LV10043B (lv)
MC (1) MC2274A1 (lv)
MX (1) MX9100441A (lv)
NO (1) NO178252C (lv)
NZ (1) NZ239222A (lv)
PT (1) PT98532B (lv)
RO (1) RO113611B1 (lv)
SG (1) SG181694G (lv)
SI (1) SI9111342B (lv)
SK (2) SK279740B6 (lv)
ZA (1) ZA916124B (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
EP3091974B1 (en) 2014-01-06 2020-04-01 Shield TX (UK) Limited Dosage regimen of ferric trimaltol
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
ATE66609T1 (de) * 1986-07-11 1991-09-15 Asta Pharma Ag Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
HRP920575A2 (en) 1995-04-30
ATE110261T1 (de) 1994-09-15
RO113611B1 (ro) 1998-09-30
AU649184B2 (en) 1994-05-12
CN1046851C (zh) 1999-12-01
IL99031A (en) 1996-09-04
FI913710A0 (fi) 1991-08-02
SI9111342B (sl) 1998-10-31
FI97951C (fi) 1997-03-25
EP0469440A1 (de) 1992-02-05
HU206268B (en) 1992-10-28
BG60900B1 (bg) 1996-06-28
AU643309B2 (en) 1993-11-11
ZA916124B (en) 1992-04-29
IE66378B1 (en) 1995-12-27
JP3061898B2 (ja) 2000-07-10
CN1058715A (zh) 1992-02-19
DE4124481A1 (de) 1992-02-06
HRP920575B1 (en) 1999-04-30
SI9111342A (sl) 1998-04-30
LT3528B (en) 1995-11-27
ES2058999T3 (es) 1994-11-01
NO913019L (no) 1992-02-04
LV10043A (lv) 1994-05-10
HK15695A (en) 1995-02-10
DE59102620D1 (de) 1994-09-29
CS240991A3 (en) 1992-03-18
JP2000229860A (ja) 2000-08-22
DK0469440T3 (da) 1994-11-14
SK279739B6 (sk) 1999-03-12
KR920003963A (ko) 1992-03-27
FI913710A (fi) 1992-02-04
CZ280475B6 (cs) 1996-01-17
CA2048367A1 (en) 1992-02-04
SG181694G (en) 1995-05-12
NO913019D0 (no) 1991-08-02
AU8158991A (en) 1992-02-06
BG94934A (bg) 1993-12-24
CA2048367C (en) 2000-05-23
SK279740B6 (sk) 1999-03-12
MC2274A1 (fr) 1993-06-23
PT98532B (pt) 1999-01-29
IL99031A0 (en) 1992-07-15
NO178252B (no) 1995-11-13
AR247484A1 (es) 1995-01-31
HUT59316A (en) 1992-05-28
EG19690A (en) 1995-09-30
EP0469440B1 (de) 1994-08-24
KR0177170B1 (ko) 1999-03-20
MX9100441A (es) 1992-04-01
IE912774A1 (en) 1992-02-12
HU912594D0 (en) 1992-01-28
JPH04243828A (ja) 1992-08-31
FI97951B (fi) 1996-12-13
NZ239222A (en) 1993-01-27
PT98532A (pt) 1992-06-30
LTIP921A (en) 1995-03-27
US5158776A (en) 1992-10-27
LV10043B (en) 1995-06-20
AU4483693A (en) 1993-11-11
JP3545300B2 (ja) 2004-07-21

Similar Documents

Publication Publication Date Title
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO871640D0 (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO911606D0 (no) Fremgangsmaate for fremstilling av glycidylazidpolymer.
NO883813D0 (no) Fremgangsmaate for fremstilling av homopolyamider.
NO178252C (no) Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
NO913692L (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
NO920636L (no) Fremgangsmaate for fremstilling av 9-amino-1,2,3,4-tetra-hydroakridin
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
NO911672L (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO903967D0 (no) Fremgangsmaate for fremstilling av dihydrocaffeinsyrederivater.
NO901687L (no) Fremgangsmaate for fremstilling av thiazetokinolin-3-karboksylsyrederivater.
FR2666581B1 (fr) Procede de preparation d'acetate de tocopherol.
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
NO874539L (no) Fremgangsmaate for fremstilling av nye farmasoeytiske preparater.
NO169337C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme nafthalenderivater.
NO882564L (no) Fremgangsmaate for fremstilling av nye aminoacylater av glycerolacetal.
NO873452L (no) Fremgangsmaate for fremstilling av galeniske preparater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees